BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30407089)

  • 1. Implementation and monitoring of decisions by pharmacy and therapeutics committees in South African public sector hospitals.
    Mashaba TP; Matlala M; Godman B; Meyer JC
    Expert Rev Clin Pharmacol; 2019 Feb; 12(2):159-168. PubMed ID: 30407089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications.
    Matlala M; Gous AG; Godman B; Meyer JC
    Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1273-1280. PubMed ID: 28776442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
    Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
    Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital pharmacy services in the Pacific Island countries.
    Penm J; Chaar B; Moles R
    J Eval Clin Pract; 2015 Feb; 21(1):51-6. PubMed ID: 25041043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulary Management Activities and Practice Implications Among Public Sector Hospital Pharmaceutical and Therapeutics Committees in a South African Province.
    Matlala M; Gous AGS; Meyer JC; Godman B
    Front Pharmacol; 2020; 11():1267. PubMed ID: 32973508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa.
    Terblanche A; Meyer JC; Godman B; Summers RS
    Hosp Pract (1995); 2018 Oct; 46(4):221-228. PubMed ID: 30092683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of medicines in Chilean public hospitals: an exploratory study.
    Collao JF; Smith F; Barber N
    BMC Health Serv Res; 2013 Jan; 13():10. PubMed ID: 23294543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prioritising drug and therapeutics committee (DTC) decisions: a national survey.
    Tan EL; Day RO; Brien JA
    Pharm World Sci; 2007 Apr; 29(2):90-6. PubMed ID: 17187221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2004.
    Pedersen CA; Schneider PJ; Scheckelhoff DJ
    Am J Health Syst Pharm; 2005 Feb; 62(4):378-90. PubMed ID: 15745890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee.
    Leonard MC; Thyagarajan R; Wilson AJ; Sekeres MA
    Am J Health Syst Pharm; 2018 Apr; 75(7):451-455. PubMed ID: 29572313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the presentation of drug information to pharmacy and therapeutics committees for formulary decisions.
    Sterné SC; Uchida KM; Iteen SA
    Am J Health Syst Pharm; 1996 May; 53(10):1162-4. PubMed ID: 8734677
    [No Abstract]   [Full Text] [Related]  

  • 13. Literature review on the structure and operation of Pharmacy and Therapeutics Committees.
    Durán-García E; Santos-Ramos B; Puigventos-Latorre F; Ortega A
    Int J Clin Pharm; 2011 Jun; 33(3):475-83. PubMed ID: 21416393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and activities of hospital drug committees in Germany.
    Thürmann PA; Harder S; Steioff A
    Eur J Clin Pharmacol; 1997; 52(6):429-35. PubMed ID: 9342577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of clinical pharmacy services in United Kingdom National Health Service hospitals.
    Cotter SM; Barber ND; McKee M
    Am J Hosp Pharm; 1994 Nov; 51(21):2676-84. PubMed ID: 7856579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organization and operation of P & T Committees in the state of Florida: a survey.
    Hatton RC; Doering PL
    Hosp Formul; 1990 Sep; 25(9):983-6, 988-9. PubMed ID: 10106259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing.
    Schönenberger N; Meyer-Massetti C; Bravo S
    Eur J Hosp Pharm; 2024 Feb; 31(2):171-174. PubMed ID: 36241377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug and therapeutics committees: the relationships among structure, function, and effectiveness.
    Plumridge RJ; Stoelwinder JU; Rucker TD
    Hosp Pharm; 1993 Jun; 28(6):492-3, 496-8, 508. PubMed ID: 10126453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Structure and activities of drug committees in Germany. Results of a survey of 143 hospitals. Pharmaco-economic Study Group and Rational Drug Therapy of the German Society of Clinical Pharmacology and Therapy].
    Harder S; Thürmann P; Steioff A
    Med Klin (Munich); 1998 Feb; 93(2):119-24. PubMed ID: 9545712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures.
    Fijn R; Brouwers JR; Knaap RJ; De Jong-Van Den Berg LT
    Br J Clin Pharmacol; 1999 Aug; 48(2):239-46. PubMed ID: 10417503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.